Although HAT1 can promote PCa and CRPC progression through upregulating AR (including AR‐V7) expression via a BRD4‐mediated pathway and knockdown of HAT1 partially re‐sensitizes CRPC cells to ENZ treatment, there are still some problems to be further studied. This evidence concerns the gene CD101 and posterior cortical atrophy.